Clinical predictive model for brain metastasis at presentation in patients with non-small-cell lung cancer (NSCLC).

被引：0
|
作者：
Acevedo-Gadea, Carlos Rodrigo
Trinkaus, Kathryn
Govindan, Ramaswamy
Morgensztern, Daniel
机构：
[1] Yale Univ, Sch Med, New Haven, CT USA
[2] Washington Univ, St Louis, MO USA
[3] Washington Univ, Sch Med, St Louis, MO USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19158
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Understanding the patient experience and treatment benefits in patients with non-small-cell lung cancer with brain metastasis
    Cella, David
    Wen, Patrick Y.
    Ervin, Claire
    Vallow, Susan
    Gilloteau, Isabelle
    DeMuro, Carla
    Mordin, Margaret
    Chassot Agostinho, Andrea
    Dine, Jennifer
    CANCER MEDICINE, 2023, 12 (12): : 13637 - 13648
  • [32] Clinical implication of neuroendocrine differentiation (NED) in non-small-cell lung cancer (NSCLC)
    Segawa, Y.
    Ogino, A.
    Nogami, N.
    Shinkai, T.
    Nishimura, R.
    Teramoto, N.
    Komori, E.
    Sawada, S.
    Yamashita, M.
    Takashima, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [33] PROGNOSTIC MODEL USING CLINICAL PARAMETERS IN NON-SMALL-CELL LUNG CANCER PATIENTS
    Kwak, Seung Min
    Cho, Jae Wha
    Ryu, Jeong Seon
    RESPIROLOGY, 2014, 19 : 157 - 157
  • [34] PROGNOSTIC MODEL USING CLINICAL PARAMETERS IN NON-SMALL-CELL LUNG CANCER PATIENTS
    Nam, Hae-seong
    Hwang, Seung-sik
    Jeon, Sang Hoon
    Cho, Jae Hwa
    Kwak, Seung-min
    Lee, Hong Lyeol
    Ryu, Jeong-seon
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S492 - S492
  • [35] Prognostic factors for clinical outcome in advanced non-small-cell lung cancer (NSCLC)
    Otero-Romero, A.
    Navarro-Domenech, I.
    Roman-Jobacho, A.
    Perez-Rozos, A.
    Fernandez-Forne, A.
    Correa-Generoso, R.
    Ordonez-Marmolejo, R.
    Garcia-Rios, I.
    Garcia-Anaya, M.
    Gomez-Millan, J.
    Medina-Carmona, J.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S751 - S751
  • [36] Impact of different patterns of metastasis in non-small-cell lung cancer patients
    da Silva, Larissy Machado
    da Silva, Gustavo Telles
    Bergmann, Anke
    Costa, Guilherme Jorge
    Zamboni, Mauro Musa
    Santos Thuler, Luiz Claudio
    FUTURE ONCOLOGY, 2021, 17 (07) : 775 - 782
  • [37] Bevacizumab suppresses the growth of established non-small-cell lung cancer brain metastases in a hematogenous brain metastasis model
    Masuda, Chinami
    Sugimoto, Masamichi
    Wakita, Daiko
    Monnai, Makoto
    Ishimaru, Chisako
    Nakamura, Ryo
    Kinoshita, Mari
    Yorozu, Keigo
    Kurasawa, Mitsue
    Kondoh, Osamu
    Yamamoto, Kaname
    CLINICAL & EXPERIMENTAL METASTASIS, 2020, 37 (01) : 199 - 207
  • [38] Bevacizumab suppresses the growth of established non-small-cell lung cancer brain metastases in a hematogenous brain metastasis model
    Chinami Masuda
    Masamichi Sugimoto
    Daiko Wakita
    Makoto Monnai
    Chisako Ishimaru
    Ryo Nakamura
    Mari Kinoshita
    Keigo Yorozu
    Mitsue Kurasawa
    Osamu Kondoh
    Kaname Yamamoto
    Clinical & Experimental Metastasis, 2020, 37 : 199 - 207
  • [39] Outcome of non-small-cell lung cancer (NSCLC) patients treated for brain metastases (BM) in a single institution
    Chaubet, M.
    Abedallaa, N.
    Le Pechoux, C.
    Planchard, D.
    Soria, J. C.
    Massard, C.
    Besse, B.
    EJC SUPPLEMENTS, 2009, 7 (02): : 521 - 522
  • [40] A Multisite Study of Molecular Profiles of Brain Metastasis in Non-Small-Cell Lung Cancer
    Kokabee, M.
    Wuu, Y-R
    Vojnic, M.
    D'Amico, R. S.
    Wernicke, A. G.
    Harshan, M.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2023, 25 (06): : S51 - S52
12345